# Evove

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/evove

- Industry: Environmental Services
- Headquarters: UK
- Website: www.evove.tech
- Total disclosed funding: $5.8M
- Latest round: Series A (Feb 16, 2023)
- Investors on record: 3

## About

Evove Limited, based in the UK, specializes in advanced membrane technology, providing innovative solutions for water filtration and separation processes to enhance efficiency and reduce energy consumption in various industries.Founded in 2015, Evove Limited is focused on developing advanced membrane technologies for water filtration applications. The company is headquartered in the UK and has successfully completed a total of 3 deals. The latest deal occurred on March 7, 2023, when Evove raised GBP 5.7 million in a Series A funding round, led by At One Ventures with participation from AM Ventures and Maven VCT. Tim Harper is the founder, and Chris Wyres serves as CEO.Evove™ specializes in advanced membrane technology tailored for water filtration and separation processes, focusing on microfiltration (MF), ultrafiltration (UF), nanofiltration (NF), and reverse osmosis (RO). The company's core product lines, Enhance and Separonics™, utilize advanced materials science and additive manufacturing to improve efficiency in conventional membrane systems. Enhance products enhance energy efficiency and reduce chemical usage, while Separonics™ provide precision-engineered membranes for uniform pore size and distribution, targeting industries requiring sophisticated water reclamation solutions across Europe, North America, and Asia-Pacific.Evove™ generates revenue primarily through B2B transactions, collaborating with water treatment facilities and industrial clients for customized membrane solutions. Revenue is derived from sales of products like Separonics™ membranes and ongoing service agreements related to maintenance and optimization, reflecting the company's strategic focus on innovation and partnership in the water treatment sector. In the most recent year reported, Evove recorded a revenue of GBP 0 and an EBITDA of GBP -56.Following the GBP 5.7 million Series A funding round in March 2023, Evove Limited plans to expand its manufacturing capacity. The company aims to introduce new membrane products and expand into new geographic markets, though specific timelines and regions for this expansion are not detailed. The recent funding will be utilized to support these initiatives, enabling Evove to capitalize on growth opportunities in the water treatment sector.

## Funding rounds

- Series A, Feb 16, 2023, $5.8M — AM Ventures, At One Ventures, Maven VCT

## Investors

- AM Ventures (https://capitalatlas.ai/funds/am-ventures) — Series A
- At One Ventures (https://capitalatlas.ai/funds/at-one-ventures) — Series A
- Maven VCT — Series A
